Krishna Institute of Medical Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krishna Institute of Medical Sciences (KIMS) has informed the exchanges that its trading window will remain closed from Tuesday, July 1, 2025, until 48 hours after the announcement of unaudited financial results for Q1 FY26 (quarter ending June 30, 2025). The closure is a mandatory step under SEBI's Insider Trading Regulations, taken ahead of the upcoming results declaration. During this period, all directors, designated employees, insiders, and their immediate relatives are prohibited from buying or selling KIMS shares. The date of the board meeting to approve the Q1 results will be communicated separately.
This is a routine compliance filing with no direct impact on the stock price. However, it signals that the Q1 FY26 results announcement is approaching, which is typically a key event that may move the stock based on performance versus expectations.